PARIS, July 10 Cegedim Strategic Data, leading provider inhealthcare research.
CSD Korea has announced the launch of its Patient Longitudinal Database inpartnership with the BIT computer company, established leader in the Korean IThealthcare market for over 25 years.
Following this launch CSD Korea will provide a wide range of analysesbased on real-life observational patient data. Patient Longitudinal can helpdefine a pharmaceutical company's strategic options when it comes to managingportfolio lifecycle challenges and opportunities. Examples of studiesinclude: market share, prescriptions and co-prescriptions, patient profiles,dynamic segments, etc.
During its client meeting, organised at the Millennium Seoul Hilton on27th May, Bruno Sarfati, CSD CEO declared: "CSD launched the firstlongitudinal patient database over 17 years ago in France (Thales) and sincethen we have continued to extend our longitudinal patient data offer. I amdelighted that CSD Korea is the 9th affiliate to launch its PatientLongitudinal database and the first in Asia".
CSD has already longitudinal patient databases in Australia, Belgium,Czech Republic, France, Germany, Italy, Spain, and the UK.
About Cegedim Strategic Data:
CSD is a leading Market Research company dedicated to the healthcareindustry and operating in more than 58 countries.
With over 35 years experience in the Pharmaceutical industry CSD(previously CAM, Thales, Zoom and Decisions Research) offers a comprehensiverange of market research services and solutions to meet the needs of itscustomers, which include more than 50 global and 500 local Pharmaceuticalcompanies. The capability to integrate primary market research with auditedpromotional data from PCPs, Specialists and Pharmacists, and merge it withlongitudinal patient level data is what sets the company apart from itscompetition.
To learn more, please see our website: www.cegedimstrategicdata.com.
Founded in 1969, Cegedim is a global technology and services companyspecializing in the healthcare field. Cegedim supplies services, technologicaltools, specialized software, data flow management services and databases. Itsofferings are targeted notably at healthcare industries, pharmaceuticalcompanies, healthcare professionals and insurance companies.
The world leader in pharmaceutical CRM, Cegedim is also one of the leadingsuppliers of strategic healthcare industry data. Cegedim employs more than8,000 people in 80 countries and generated revenue of 753 million euro in2007. To learn more, please visit our website: www.cegedim.com.
Listed on NYSE Euronext Paris, compartment B - ISIN FR0000053506 - ReutersCGDM.PA - Bloomberg CGMMedia Inquiries: CEGEDIM STRATEGIC DATA Sophie Dequae Global Marketing & Communication Tel: +33 (0)1 49 09 83 62 [email protected]
CEGEDIM Aude Balleydier Media Relations Tel: + 33 (0)1 49 09 68 81 [email protected]
SOURCE Cegedim Strategic Data